Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoscintigraphy in cancer care

A B Delaloye1, B Delaloye

  • 1Division de Médecine Nucléaire, Centre Hospitalier, Universitaire Vaudois, Lausanne, Switzerland.

Cancer
|February 1, 1994
PubMed
Summary

Immunoscintigraphy can detect recurrent gastrointestinal and ovarian tumors earlier than other methods. More multicenter trials are needed to establish its clinical efficacy and cost-benefit for widespread adoption.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.

Cancer biotherapy & radiopharmaceuticals·2002
Same author

F+0 renography in neonates and infants younger than 6 months: an accurate method to diagnose severe obstructive uropathy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2001
Same author

Combination of clinical and V/Q scan assessment for the diagnosis of pulmonary embolism: a 2-year outcome prospective study.

European journal of nuclear medicine·2000
Same author

Radioimmunotherapy of colorectal cancer liver metastases: combination with radiotherapy.

Annals of the New York Academy of Sciences·2000
Same author

[Investigation of the urinary tract in children in nuclear medicine].

Revue medicale de la Suisse romande·2000
Same author

Nuclear cardiology: a European perspective.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·1998

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Immunoscintigraphy shows potential for early detection of recurrent gastrointestinal and ovarian tumors.
  • Current diagnostic methods lack the sensitivity for early postoperative follow-up detection.
  • Clinical adoption of immunoscintigraphy is limited despite published evidence.

Purpose of the Study:

  • To highlight the underutilization of immunoscintigraphy in clinical practice.
  • To emphasize the need for robust clinical trials to validate its efficacy.
  • To suggest a cost-benefit analysis to guide future research and adoption.

Main Methods:

  • Review of existing publications on immunoscintigraphy for tumor recurrence.
  • Identification of factors limiting clinical acceptance.
  • Proposal for designing future multicenter trials.

Main Results:

  • Immunoscintigraphy demonstrates earlier detection capabilities compared to standard methods.
  • Lack of large-scale, well-designed multicenter trials is a primary barrier.
  • Cost-benefit analysis is proposed as a crucial component for trial design.

Conclusions:

  • Immunoscintigraphy is a promising tool for early detection of tumor recurrence.
  • Further well-designed multicenter trials are essential for clinical validation.
  • A cost-benefit approach can facilitate the design of impactful studies and promote wider clinical use.

Related Experiment Videos